Articles in Hot Topics
Stem cells, the precursors to all differentiated cells, can now be modified to improve healing rates. Daniel Anderson at MIT engineered stem cells with a gene that promotes blood vessel growth. Because tissue repair requires …
Medical researchers at University College London have come up with a way to produce regulatory T-cells, highly specialized immune cells that regulate the body’s immune response. Normally making up less than 1% of the body’s …
Obstructive sleep apnea (OSA) refers to short periods of non-breathing that occurs during sleep, as a result of a collapse or obstruction of the airway. It is almost always accompanied by snoring.
Sleep apnea is significant because if …
As of October 30, 2009, 16,870,00 doses of the H1N1 (Swine) flu vaccine have been shipped to states out of the 23,160,700 allocated doses. Distribution of the vaccine is managed by health departments using a …
David A. Kessler, M.D., the former Food and Drug Administration commissioner and author of several books about nutrition, asks this question in his attempt to understand why certain foods have addictive qualities.
To understand this, we …
If as health care workers, we have an ethical obligation to do all we can to protect our patients from harm, should we then be obligated to receive the H1N1 vaccine? Consider all the patients …
Benzodiazepines, a class of sedatives that includes Ativan, Xanax and Valium, may actually interfere with the brain’s ability to consolidate memories as researchers from Ben-Gurion University of the Negev in Beer Sheva, Israel have discovered.
When …
Here’s what we know about the H1N1 (Swine) flu vaccine according to the Centers for Disease Control (CDC).
CDC anticipates that 2 doses of the vaccine will be needed for children under 10
1 dose of the …
Taking non-steroidal anti-inflammatories (NSAIDs) or statins (used to lower cholesterol) lowers PSA levels in men according to a study at Duke University of 1,214 men who were followed from 1990 to 2006.
The men in this study …
According to the Centers for Disease Control (CDC), the new H1N1 flu vaccine (the live, attenuated virus) should be available by the first week of October. There are currently 2 types of vaccine available:
live, attenuated …
